NOVOPHARM FORMULATIONS PRIVATE LIMITED

About GSTIN 24AAACN6793Q1ZQ

NOVOPHARM FORMULATIONS PRIVATE LIMITED is a Private Limited Company registered under GST in Gujarat with GSTIN 24AAACN6793Q1ZQ. The GST registration was obtained on 01 July 2017. The current status of this GST registration is .

The PAN associated with this GSTIN is AAACN6793Q. The registration type is Regular. The primary nature of business activities is Factory / Manufacturing, Wholesale Business. This GST registration is linked to N&G FORMULATIONS PRIVATE LIMITED (CIN: U36900DL2019PTC358553).

GST Registration Details

GSTIN
24AAACN6793Q1ZQ
PAN Number
Legal Name
NOVOPHARM FORMULATIONS PRIVATE LIMITED
Trade Name
Not Available
Status
GST Type
Regular
State / Jurisdiction
Gujarat (Code: 24)
Entity Type
Private Limited Company
Nature of Business
Factory / Manufacturing, Wholesale Business
Registration Date
01 Jul 2017
Principal Place of Business
raj mandir appartment 105 62 R C DUTT ROAD ALKAPURI Gujarat

Linked Company Information

CIN
U36900DL2019PTC358553
Company Class
Private
Company Status
Active

Frequently Asked Questions

Is 24AAACN6793Q1ZQ a valid GST number?

Yes, 24AAACN6793Q1ZQ is a valid GSTIN registered under the Goods and Services Tax (GST) system in India. It belongs to NOVOPHARM FORMULATIONS PRIVATE LIMITED in Gujarat. The current status of this registration is .

What is the legal name registered under 24AAACN6793Q1ZQ?

The legal name registered under GSTIN 24AAACN6793Q1ZQ is NOVOPHARM FORMULATIONS PRIVATE LIMITED.

What is the PAN linked to 24AAACN6793Q1ZQ?

The PAN (Permanent Account Number) linked to GSTIN 24AAACN6793Q1ZQ is AAACN6793Q. The first two digits of a GSTIN represent the state code (24 for Gujarat), followed by the 10-character PAN, an entity code, the letter 'Z', and a check digit.

Which company is 24AAACN6793Q1ZQ linked to?

GSTIN 24AAACN6793Q1ZQ is linked to N&G FORMULATIONS PRIVATE LIMITED (CIN: U36900DL2019PTC358553), a Private company registered in India.

Data last updated: 20 Feb 2026, 05:35 | Record updated: 20 Feb 2026